KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Sales (2016 - 2025)

Historic Return on Sales for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 0.28%.

  • Resmed's Return on Sales rose 100.0% to 0.28% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.28%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.27% for FY2025, which is 500.0% up from last year.
  • As of Q4 2025, Resmed's Return on Sales stood at 0.28%, which was up 100.0% from 0.26% recorded in Q3 2025.
  • Resmed's Return on Sales' 5-year high stood at 0.28% during Q1 2025, with a 5-year trough of 0.1% in Q1 2021.
  • Over the past 5 years, Resmed's median Return on Sales value was 0.22% (recorded in 2021), while the average stood at 0.22%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -3100bps in 2021, then surged by 3100bps in 2022.
  • Resmed's Return on Sales (Quarter) stood at 0.23% in 2021, then decreased by -3bps to 0.22% in 2022, then decreased by -17bps to 0.18% in 2023, then skyrocketed by 50bps to 0.27% in 2024, then rose by 3bps to 0.28% in 2025.
  • Its Return on Sales stands at 0.28% for Q4 2025, versus 0.26% for Q3 2025 and 0.28% for Q2 2025.